Search Results - "Nuske, K"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Interferon-alpha suppresses the antiapoptotic effect of NF-kB and sensitizes renal cell carcinoma cells in vitro to chemotherapeutic drugs by Steiner, T, Junker, U, Henzgen, B, Nuske, K, Durum, S K, Schubert, J

    Published in European urology (01-04-2001)
    “…Immunochemotherapy (ICT) with interleukin-2 (IL-2) and interferon-alpha (IFNalpha) with a secondary effector (5-fluorouracil, 5 FU) is the only promising…”
    Get more information
    Journal Article
  2. 2

    PAR-1- and PAR-3-type thrombin receptor expression in primary cultures of human renal cell carcinoma cells by Kaufmann, R, Junker, U, Nuske, K, Westermann, M, Henklein, P, Scheele, J, Junker, K

    Published in International journal of oncology (01-01-2002)
    “…In this study, we report coexpression of proteinase-activated receptor (PAR)-1- and PAR-3-type thrombin receptors in primary cultures obtained from surgically…”
    Get more information
    Journal Article
  3. 3

    The serine proteinase thrombin promotes migration of human renal carcinoma cells by a PKA-dependent mechanism by Kaufmann, R., Junker, U., Junker, K., Nuske, K., Ranke, C., Zieger, M., Scheele, J.

    Published in Cancer letters (28-06-2002)
    “…In this study, we demonstrated that thrombin activates protein kinase C (PKC), mitogen activated protein kinases (MAP kinases), transcription factor nuclear…”
    Get full text
    Journal Article
  4. 4

    ELEVATED PLASMA TGF-β1 IN RENAL DISEASES: CAUSE OR CONSEQUENCE? by Junker, U, Haufe, C.C, Nuske, K, Rebstock, K, Steiner, T, Wunderlich, H, Junker, K, Reinhold, D

    Published in Cytokine (Philadelphia, Pa.) (01-07-2000)
    “…We previously reported elevated levels of TGF-β1 in patients with renal carcinoma. Certain aspects led us to ask whether they might be caused by chronic damage…”
    Get full text
    Journal Article
  5. 5

    Transforming Growth Factor Beta 1 is Significantly Elevated in Plasma of Patients Suffering from Renal Cell Carcinoma by Junker, U., Knoefel, B., Nuske, K., Rebstock, K., Steiner, T., Wunderlich, H., Junker, K., Reinhold, D.

    Published in Cytokine (Philadelphia, Pa.) (01-10-1996)
    “…The levels of active and latent transforming growth factor beta 1 (aTGF-β1, ITGF=β1, respectively) in plasma samples were measured by enzyme-linked…”
    Get full text
    Journal Article
  6. 6

    Differential expression of cytokines and cytokine receptors in renal cell carcinoma by Steiner, T, Junker, U, Salamon, A, Nuske, K, Schubert, J

    Published in Urologia internationalis (01-01-2001)
    “…Modulation of immunomechanisms by tumor cells can be caused by secretion of cytokines. In vitro data are usually gained in culture systems. It is debatable…”
    Get more information
    Journal Article
  7. 7

    Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-beta 1 in primary cultures and modulate T lymphocyte blast transformation by Knoefel, B, Nuske, K, Steiner, T, Junker, K, Kosmehl, H, Rebstock, K, Reinhold, D, Junker, U

    Published in Journal of interferon & cytokine research (01-02-1997)
    “…We investigated the immunomodulatory capacity of primary cultures of renal cell carcinomas (RCC) by assessing production of cytokines and modulation of…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Elevated plasma TGF-beta1 in renal diseases: cause or consequence? by Junker, U, Haufe, C C, Nuske, K, Rebstock, K, Steiner, T, Wunderlich, H, Junker, K, Reinhold, D

    Published in Cytokine (Philadelphia, Pa.) (01-07-2000)
    “…We previously reported elevated levels of TGF-beta1 in patients with renal carcinoma. Certain aspects led us to ask whether they might be caused by chronic…”
    Get full text
    Journal Article
  10. 10

    Primary culture of different renal cell carcinoma cells with respect to immunomodulatory effects by Knöfel, B, Junker, U, Nuske, K, el-Seweifi, A, Junker, K, Kosmehl, H, Jäger, L

    Published in Immunitat und Infektion (01-04-1995)
    “…The presented results show that renal cell carcinomas (RCC) have partial immunomodulatory capacity (production of cytokines as IL-6, -10, -11; modulation of…”
    Get more information
    Journal Article